E Enovis Corporation
| Market Cap | $1.30B |
| P/E Ratio | — |
| Forward P/E | 5.71 |
| Dividend Yield | — |
| Beta | 1.59 |
| 52W Range | $21.46 - $37.35 |
| # Hedge Funds | 2 |
| Sector | Healthcare |
| Industry | Medical Devices |
Hedge Fund Ownership
| Investor 2 | % of Portfolio Weight of this stock in the investor's portfolio | Value Total dollar value of the position | Shares Number of shares held | Activity Portfolio change type: New, Increased, Decreased, or Sold |
|---|---|---|---|---|
| Pat Dorsey Dorsey Asset Management | 5.28% | $60.72M | 2,279,200 | Reduce 5.01% |
| Mason Hawkins Southeastern Asset Management | 0.05% | $1.18M | 44,258 | Reduce 18.73% |
Insider Trading
| Insider Name of the company insider who made the trade 14 | Type Purchase (buy) or Sale (sell) | Shares Number of shares traded | Price Price per share at time of transaction | Value Total dollar value of the transaction | Trade Date Date the transaction was executed | Filing Date Date the SEC filing was submitted |
|---|---|---|---|---|---|---|
| Engert OliverChief Administrative Officer | Buy | 1,000 | $23.74 | $23.74K | 13 Mar 2026 | 13 Mar 2026 |
| Engert OliverChief Administrative Officer | Buy | 1,000 | $23.93 | $23.93K | 10 Mar 2026 | 10 Mar 2026 |
| Engert OliverChief Administrative Officer | Buy | 1,000 | $23.39 | $23.39K | 09 Mar 2026 | 06 Mar 2026 |
| Engert OliverChief Administrative Officer | Buy | 500 | $24.48 | $12.24K | 06 Mar 2026 | 06 Mar 2026 |
| Engert OliverChief Administrative Officer | Buy | 250 | $24.28 | $6.07K | 06 Mar 2026 | 06 Mar 2026 |
| Engert OliverChief Administrative Officer | Buy | 250 | $25.10 | $6.28K | 04 Mar 2026 | 05 Mar 2026 |
| Engert OliverChief Administrative Officer | Buy | 1,000 | $24.77 | $24.77K | 03 Mar 2026 | 05 Mar 2026 |
| Engert OliverChief Administrative Officer | Buy | 1,000 | $25.50 | $25.50K | 27 Feb 2026 | 03 Mar 2026 |
| PRYOR DANIEL A | Sale | 333 | $27.22 | $9.06K | 09 Dec 2025 | 11 Dec 2025 |
| PRYOR DANIEL A | Sale | 333 | $27.18 | $9.05K | 09 Dec 2025 | 11 Dec 2025 |
| PRYOR DANIEL A | Sale | 333 | $27.21 | $9.06K | 09 Dec 2025 | 11 Dec 2025 |
| PRYOR DANIEL A | Sale | 666 | $27.21 | $18.12K | 09 Dec 2025 | 11 Dec 2025 |
| KLECKNER JOHNPrincipal Accounting Officer | Buy | 2,468 | $30.32 | $74.83K | 25 Nov 2025 | 28 Nov 2025 |
| John KlecknerPrincipal Accounting Officer | Buy | 2,468 | $30.32 | $74.83K | 25 Nov 2025 | 28 Nov 2025 |
Frequently Asked Questions
What is ENOV stock price today?
Enovis Corporation (ENOV) is currently trading at $22.64. The stock has a 52-week range of $21.46 to $37.35 and a market capitalization of $1.30B.
Is ENOV a good stock to buy in 2026?
Enovis Corporation has a P/E ratio of N/A (forward P/E: 5.7), a dividend yield of none, and 1-year performance of -33.0%. 2 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.
Are insiders buying or selling ENOV stock?
There have been 14 insider transactions for ENOV in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.
How has ENOV stock performed over the past year?
Enovis Corporation (ENOV) has returned -33.0% over the past 12 months. The stock traded between $21.46 and $37.35 during this period, and is currently at $22.64.
Which hedge funds own ENOV (Enovis Corporation)?
2 tracked hedge funds currently hold ENOV in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.
What is ENOV's market cap and valuation?
Enovis Corporation (ENOV) has a market capitalization of $1.30B. The trailing P/E ratio is N/A and forward P/E is 5.7. The stock is classified in the Healthcare sector.
What is ENOV's revenue and profitability?
Enovis Corporation reported revenue of $2.25B with net income of N/A and a profit margin of N/A. The stock has a beta of 1.59.
What sector is ENOV in and who are its biggest institutional holders?
Enovis Corporation (ENOV) operates in the Healthcare sector. It is held by 2 tracked hedge funds. See the ownership table above for the complete list.